Universidad Rey Juan Carlos   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Madrid Spain (1996)

Organization Overview

First Clinical Trial
2014
NCT02188394
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Center for Sport Studies, Rey Juan Carlos University | César Fernández-de-las-Peñas | Hospital Rey Juan carlos | Hospital Rey Juan Carlos | HOSPITAL REY JUAN CARLOS | Hospital Universitario Rey Juan Carlos | H. U. REY JUAN CARLOS | Juan José Arjona Retamal | Rey Juan Carlos University | Universidad Rey Juan Carlos | Universidad Rey Juan Carlos (Madrid)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 2)

Communicable Diseases (Phase 3)

Fissure in Ano (Phase 3)

Infections (Phase 3)

Joint Diseases (Phase 2)

Migraine Disorders (Phase 2)

Pain, Postoperative (Phase 3)

Surgical Wound Infection (Phase 3)

Temporomandibular Joint Disorders (Phase 2)

Temporomandibular Joint Dysfunction Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 12